Immunostaining revealed that the tumor cells were strongly positive for CK20 (Figure 3D) and CDX2 (Figure 3E), whereas the endometrial glands and stroma did not react with CK20 or CDX2. This evidence concerns the gene CDX2 and neoplasm.